MDxHealth (MDXH) Net Cash Flow (2021 - 2026)

MDxHealth has reported Net Cash Flow for 6 years, with the latest figure at $22.9 million in Q1 2026.

• Quarterly Net Cash Flow fell 12.15% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (down 129.73% YoY) and the FY2025 annual result came in at -$30.0 million, down 264.48% from the prior year.
• Net Cash Flow advanced to $22.9 million in Q1 2026 per MDXH's latest filing, from -$21.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $27.4 million in Q3 2024 and troughed at -$21.4 million in Q3 2025.
• A 5-year average of -$160300.0 and a median of -$8.2 million in 2023 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow advanced 25.56% in 2023, then tumbled 177.89% in 2025.
• Over 5 years, Net Cash Flow stood at -$10.4 million in 2022, then rose by 25.56% to -$7.7 million in 2023, then soared by 48.95% to -$4.0 million in 2024, then plunged by 440.83% to -$21.4 million in 2025, then surged by 207.2% to $22.9 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $22.9 million, -$21.4 million, and -$16.3 million for Q1 2026, Q3 2025, and Q2 2025 respectively.